Amoxicillin Alternative in Short Supply, University of Utah Says

Three major pharmaceutical companies have limited supply of generic Augmentin, a popular alternative for the antibiotic amoxicillin, which has been in short supply for nearly a month in the US.

Hikma Pharmaceuticals Plc, Novartis AG’s Sandoz unit, and Teva Pharmaceutical Industries Ltd. have constrained supply of some doses of the medicine, the University of Utah’s drug information service reported Friday.

The medication is a combination of amoxicillin and clavulanic acid, and it’s used for treating bacterial infections in adults and children. Augmentin can be prescribed instead of amoxicillin alone, a popular drug for common childhood ailments such as ...